# A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia

> **NCT01345214** · PHASE1 · TERMINATED · sponsor: **Ono Pharma USA Inc** · enrollment: 17 (actual)

## Conditions studied

- Chemotherapy-Induced Thrombocytopenia

## Interventions

- **DRUG:** ONO-7746

## Key facts

- **NCT ID:** NCT01345214
- **Lead sponsor:** Ono Pharma USA Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-05
- **Primary completion:** 2014-02
- **Final completion:** —
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** The study was terminated due to slow accrual of subjects.
- **Last updated:** 2014-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01345214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01345214, "A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01345214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*